SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Cadrenal Therapeutics announced plans to submit a Rare Pediatric Disease Designation request to the FDA for tecarfarin to treat pediatric Kawasaki disease patients with coronary ar…
Grace Therapeutics released a June 2026 corporate presentation outlining its drug development pipeline and regulatory strategy. The company is pursuing FDA approval for GTx-104 for…
Grace Therapeutics announced it received a Complete Response Letter from the FDA for its GTx-104 new drug application with issues related to manufacturing controls and non-clinical…
Enanta Pharmaceuticals announced advancement of zelicapavir into a registrational Phase 2b/3 clinical trial for high-risk RSV adults, with Phase 2b data expected in 2027, plus a pe…
Green Thumb Industries Inc. has filed amended and restated articles of incorporation with updated governance provisions. The filing outlines standard corporate governance procedure…
Kiora Pharmaceuticals announced preclinical data showing KIO-300 significantly reduced seizure-associated activity in a temporal lobe epilepsy model, suggesting therapeutic potenti…
NovoCure announced topline results from its Phase 3 TRIDENT trial evaluating earlier initiation of Tumor Treating Fields therapy in newly diagnosed glioblastoma, which failed to me…
Designer Brands Inc. updated its corporate governance bylaws, including provisions for shareholder meetings, notice requirements, and board authority. The filing is administrative …
The FDA approved the first generic version of Xofluza (baloxavir marboxil), a single-dose treatment for acute uncomplicated influenza. The approval applies to patients 5 years of a…
Angel Studios (formerly Southport Acquisition Corporation) amended its certificate of incorporation effective June 17, 2026, authorizing 701 million shares including 700 million co…
The Federal Reserve's Federal Open Market Committee has issued a statement regarding monetary policy decisions and economic conditions. The specific details of policy actions and e…
The Federal Reserve Board and Federal Open Market Committee released their economic projections following the June 16-17 meeting. The projections provide officials' assessments of …
Rumble Inc. filed a second amendment to its certificate of incorporation, effective June 15, 2026, increasing total authorized shares from prior levels to 1.7 billion shares across…
Dogwood Therapeutics amended its Certificate of Incorporation to increase total authorized shares to 200 million, comprising 195 million common shares and 5 million preferred share…
HEICO Corporation executed a fourth amendment to its revolving credit facility originally dated November 2017, modifying certain provisions with Truist Bank as administrative agent…
Corcept Therapeutics resubmitted its New Drug Application to the FDA for relacorilant, incorporating additional data analyses requested by the agency, with an expected six-month re…
T1 Energy Inc. increased authorized common stock to 1 billion shares while maintaining 10 million preferred shares. The amendment, effective June 18, 2026, provides capital flexibi…
Medalist Diversified filed Articles of Amendment to its Maryland charter adding definitions related to share ownership restrictions and Section 382 tax code compliance. The amendme…
Flag Ship Acquisition Corp amended its articles to extend the business combination deadline from June 2026 to June 2027, with up to 12 monthly extensions contingent on sponsor fund…
iQSTEL Inc. filed an amended and restated certificate of designation for its Series B preferred stock on June 17, 2026, approved by stockholder vote. The amendment modifies the vot…